Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1993 1
1994 1
1995 1
1996 1
1997 2
1998 1
1999 1
2000 3
2001 3
2002 4
2003 2
2004 5
2005 2
2006 4
2007 5
2008 1
2009 7
2010 6
2011 2
2012 4
2013 2
2014 5
2015 3
2016 2
2017 4
2018 10
2019 7
2020 5
2021 5
2022 4
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Results by year

Filters applied: . Clear all
Page 1
Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children.
Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, Berelowitz M, Dhillon AP, Thomson MA, Harvey P, Valentine A, Davies SE, Walker-Smith JA. Wakefield AJ, et al. Lancet. 1998 Feb 28;351(9103):637-41. doi: 10.1016/s0140-6736(97)11096-0. Lancet. 1998. PMID: 9500320 Retracted.
FINDINGS: Onset of behavioural symptoms was associated, by the parents, with measles, mumps, and rubella vaccination in eight of the 12 children, with measles infection in one child, and otitis media in another. ...Behavioural disorders included …
FINDINGS: Onset of behavioural symptoms was associated, by the parents, with measles, mumps, and rubella vaccination
Modeling human adaptive immune responses with tonsil organoids.
Wagar LE, Salahudeen A, Constantz CM, Wendel BS, Lyons MM, Mallajosyula V, Jatt LP, Adamska JZ, Blum LK, Gupta N, Jackson KJL, Yang F, Röltgen K, Roskin KM, Blaine KM, Meister KD, Ahmad IN, Cortese M, Dora EG, Tucker SN, Sperling AI, Jain A, Davies DH, Felgner PL, Hammer GB, Kim PS, Robinson WH, Boyd SD, Kuo CJ, Davis MM. Wagar LE, et al. Nat Med. 2021 Jan;27(1):125-135. doi: 10.1038/s41591-020-01145-0. Epub 2021 Jan 11. Nat Med. 2021. PMID: 33432170 Free PMC article.
Most of what we know about adaptive immunity has come from inbred mouse studies, using methods that are often difficult or impossible to confirm in humans. In addition, vaccine responses in mice are often poorly predictive of responses to those same vaccines in huma …
Most of what we know about adaptive immunity has come from inbred mouse studies, using methods that are often difficult or impossible to con …
Vaccine Adverse Events: Separating Myth from Reality.
Spencer JP, Trondsen Pawlowski RH, Thomas S. Spencer JP, et al. Am Fam Physician. 2017 Jun 15;95(12):786-794. Am Fam Physician. 2017. PMID: 28671426 Free article. Review.
The measles, mumps, and rubella vaccine is not associated with autism. Vaccines are associated with local reactions, such as pain and erythema. ...
The measles, mumps, and rubella vaccine is not associated with autism. Vaccines are associated with local …
Pain caused by measles, mumps, and rubella vaccines: A systematic literature review.
Willame C, Henry O, Lin L, Vetter V, Baril L, Praet N. Willame C, et al. Vaccine. 2017 Oct 9;35(42):5551-5558. doi: 10.1016/j.vaccine.2017.08.068. Vaccine. 2017. PMID: 28893478 Free article. Review.
This review describes and assesses the intensity of pain experienced by children post-vaccination with widely used Measles-Mumps-Rubella (MMR) vaccines. ...In this context, it is very important to understand which physicochemical properti …
This review describes and assesses the intensity of pain experienced by children post-vaccination with widely used Measles
Live-attenuated measles, mumps, and rubella booster vaccine in children diagnosed with rheumatic disease: A single-center study.
Çakmak F, Akgün Ö, Demirkan FG, Tanatar A, Kayaalp GK, Keskindemirci G, Guliyeva V, Ömeroğlu RE, Gökçay EG, Ayaz NA. Çakmak F, et al. Eur J Pediatr. 2023 Jan;182(1):135-140. doi: 10.1007/s00431-022-04646-x. Epub 2022 Oct 13. Eur J Pediatr. 2023. PMID: 36224436
To evaluate the safety profile of measles, mumps and rubella (MMR) booster in children diagnosed with rheumatic diseases receiving biological agents. ...None of the patients had disease exacerbation after vaccination, and three patients had mild side e …
To evaluate the safety profile of measles, mumps and rubella (MMR) booster in children diagnosed with rheumatic disease …
Efficacy of Intralesional Measles Mumps Rubella Vaccine in the Treatment of Verruca Vulgaris: An Interventional Study.
Surani AS, Un R, Marfatia Y. Surani AS, et al. Cureus. 2023 Jan 29;15(1):e34338. doi: 10.7759/cureus.34338. eCollection 2023 Jan. Cureus. 2023. PMID: 36865954 Free PMC article.
Aims and objectives To study the efficacy of the intralesional measles, mumps, and rubella (MMR) vaccine in verruca vulgaris and its side effects. ...The response rate may increase if a higher concentration of vaccine (0.5ml) and additional dose …
Aims and objectives To study the efficacy of the intralesional measles, mumps, and rubella (MMR) vaccine in verr …
A new combination vaccine for measles, mumps, rubella and varicella.
Zareba G. Zareba G. Drugs Today (Barc). 2006 May;42(5):321-9. doi: 10.1358/dot.2006.42.5.973586. Drugs Today (Barc). 2006. PMID: 16801995 Review.
ProQuad is a recently approved combination vaccine for simultaneous vaccination against measles, mumps, rubella and varicella in children aged 12 months to 12 years. It combines two well-established vaccines: Measles, Mumps, …
ProQuad is a recently approved combination vaccine for simultaneous vaccination against measles, mumps, rubel
A Comparative Analysis of Efficacy of Intralesional Mumps-Measles-Rubella Vaccine Versus 5-Fluorouracil in the Treatment of Palmoplantar Warts.
Sunny AS, Doshi BR. Sunny AS, et al. Indian Dermatol Online J. 2022 Sep 5;13(5):611-616. doi: 10.4103/idoj.idoj_39_22. eCollection 2022 Sep-Oct. Indian Dermatol Online J. 2022. PMID: 36304636 Free PMC article.
AIM: To evaluate the efficacy and safety of intralesional mumps-measles-rubella (MMR) vaccine versus 5-fluorouracil (5-FU) in the treatment of palmoplantar warts. ...LIMITATION: Smaller sample size and lack of follow-up to evaluate for possible recurre …
AIM: To evaluate the efficacy and safety of intralesional mumps-measles-rubella (MMR) vaccine versus 5-fluoroura …
Evaluation of the Safety and Immunogenicity of M-M-RII (Combination Measles-mumps-rubella Vaccine): Clinical Trials of Healthy Children and Adults Published Between 2010 and 2019.
Nyaku M, Richardson E, Martinon-Torres F, Kuter BJ. Nyaku M, et al. Pediatr Infect Dis J. 2021 Nov 1;40(11):1046-1054. doi: 10.1097/INF.0000000000003273. Pediatr Infect Dis J. 2021. PMID: 34310506
BACKGROUND: The safety and immunogenicity of M-M-RII (measles, mumps and rubella virus vaccine live, Merck & Co., Inc., West Point, PA)-the only combined measles, mumps and rubella vaccine licensed for use in the United …
BACKGROUND: The safety and immunogenicity of M-M-RII (measles, mumps and rubella virus vaccine live, Merck & …
Measles, mumps, and rubella revaccination in children after completion of chemotherapy and hematopoietic stem cell transplantation: a single-center prospective efficacy and safety analysis.
Wang M, Yuan Q, Deng PF, Fei Y, Zhang H, Zhou F, Chen WJ, Cao Q, Chen J, Gao YJ. Wang M, et al. World J Pediatr. 2023 Nov;19(11):1062-1070. doi: 10.1007/s12519-023-00721-x. Epub 2023 Apr 23. World J Pediatr. 2023. PMID: 37087716
This study aimed to evaluate the impact of these treatments on the decrease in antibody titers of the measles, mumps, and rubella (MMR) vaccine and seroconversion post-revaccination of MMR. ...Importantly, our study clearly demonstrated positive seroco …
This study aimed to evaluate the impact of these treatments on the decrease in antibody titers of the measles, mumps, and r
104 results